Thrombospondin-1 expression is increased during follicular atresia in the primate ovary

Endocrinology

Volumn 149, Issue 1, 2008, Pages 185-192

  Thomas, Fiona H ^a   Wilson, Helen ^a   Silvestri, Audrey ^a   Fraser, Hamish M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CLOPROSTENOL; DECOY RECEPTOR 3; GONADORELIN ANTAGONIST; GONADOTROPIN; MESSENGER RNA; TEVERELIX; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR 3; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FOLLICULAR PHASE; GRANULOSA CELL; HORMONE RELEASE; MARMOSET; NONHUMAN; OVARY; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE DEVELOPMENT; PRIMATE; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD36; CALLITHRIX; FEMALE; FOLLICULAR ATRESIA; GENE EXPRESSION REGULATION; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; OVARY; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; THROMBOSPONDIN 1;

EID: 37549050951     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0835     Document Type: Article

References (44)

1. Moley KH, Schreiber JR 1995 Ovarian follicular growth, ovulation and atresia. Endocrine, paracrine and autocrine regulation. Adv Exp Med Biol 377:103-119
2. Fraser HM 2006 Regulation of the ovarian follicular vasculature. Reprod Biol Endocrinol 4:18
3. Stouffer RL, Martinez-Chequer JC, Molskness TA, Xu F, Hazzard TM 2001 Regulation and action of angiogenic factors in the primate ovary. Arch Med Res 32:567-575
4. Wulff C, Wilson H, Wiegand SJ, Rudge JS, Fraser HM 2002 Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2. Endocrinology 143:2797-2807
5. Zimmermann RC, Hartman T, Kavic S, Pauli SA, Bohlen P, Sauer MV, Kitajewski J 2003 Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development. J Clin Invest 112:659-669
6. Ferrara N 2004 Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581-611
7. Taylor PD, Hillier SG, Fraser HM 2004 Effects of GnRH antagonist treatment on follicular development and angiogenesis in the primate ovary. J Endocrinol 183:1-17
8. Hanahan D, Folkman J 1996 Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364
9. Lawler J 2002 Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med 6:1-12
10. Gao AG, Lindberg FP, Finn MB, Blystone SD, Brown EJ, Frazier WA 1996 Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 271:21-24
11. Pfander D, Cramer T, Deuerling D, Weseloh G, Swoboda B 2000 Expression of thrombospondin-1 and its receptor CD36 in human osteoarthritic cartilage. Ann Rheum Dis 59:448-454
12. Carron JA, Wagstaff SC, Gallagher JA, Bowler WB 2000 A CD36-binding peptide from thrombospondin-1 can stimulate resorption by osteoclasts in vitro. Biochem Biophys Res Commun 270:1124-1127
13. Volpert OV, Lawler J, Bouck NP 1998 A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1. Proc Natl Acad Sci USA 95:6343-6348
14. Volpert OV, Tolsma SS, Pellerin S, Feige JJ, Chen H, Mosher DF, Bouck N 1995 Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun 217:326-332
15. Guo N, Krutzsch HC, Inman JK, Roberts DD 1997 Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res 57:1735-1742
16. Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N 2000 Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 6:41-48
17. Petrik JJ, Gentry PA, Feige JJ, LaMarre J 2002 Expression and localization of thrombospondin-1 and -2 and their cell-surface receptor, CD36, during rat follicular development and formation of the corpus luteum. Biol Reprod 67:1522-1531
18. Greenaway J, Gentry PA, Feige JJ, LaMarre J, Petrik JJ 2005 Thrombospondin and vascular endothelial growth factor are cyclically expressed in an inverse pattern during bovine ovarian follicle development. Biol Reprod 72:1071-1078
19. Greenaway J, Lawler J, Moorehead R, Bornstein P, Lamarre J, Petrik J 2007 Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1). J Cell Physiol 210:807-818
20. Iruela-Arispe ML, Porter P, Bornstein P, Sage EH 1996 Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J Clin Invest 97:403-412
21. Wulff C, Wilson H, Rudge JS, Wiegand SJ, Lunn SF, Fraser HM 2001 Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trapA40. J Clin Endocrinol Metab 86:3377-3386
22. Fraser HM, Dickson SE, Morris KD, Erickson GF, Lunn SF 1999 The effect of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate. Hum Reprod 14:2054-2060
23. Gilchrist RB, Wicherek M, Heistermann M, Nayudu PL, Hodges JK 2001 Changes in follicle-stimulating hormone and follicle populations during the ovarian cycle of the common marmoset. Biol Reprod 64:127-135
24. Summers PM, Wennink CJ, Hodges JK 1985 Cloprostenol-induced luteolysis in the marmoset monkey (Callithrix jacchus). J Reprod Fertil 73:133-138
25. Holash J, Davis S, Papadopoulos N, Croll SD, Ho L, Russell M, Boland P, Leidich R, Hylton D, Burova E, Ioffe E, Huang T, Radziejewski C, Bailey K, Fandl JP, Daly T, Wiegand SJ, Yancopoulos GD, Rudge JS 2002 VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci USA 99:11393-11398
26. Fraser HM, Wilson H, Wulff C, Rudge JS, Wiegand SJ 2006 Administration of vascular endothelial growth factor Trap during the 'post-angiogenic' period of the luteal phase causes rapid functional luteolysis and selective endothelial cell death in the marmoset. Reproduction 132:589-600
27. Thomas FH, Telfer EE, Fraser HM 2007 Expression of anti-Mullerian hormone protein during early follicular development in the primate ovary in vivo is influenced by suppression of gonadotropin secretion and inhibition of vascular endothelial growth factor. Endocrinology 148:2273-2281
28. Fluker MR, Marshall LA, Monroe SE, Jaffe RB 1991 Variable ovarian response to gonadotropin-releasing hormone analogue-induced gonadotropin deprivation during different phases of the menstrual cycle. J Clin Endocrinol Metab 72:912-919
29. Hall JE, Bhatta N, Adams JM, Rivier JE, Vale WW, Crowley Jr WF 1991 Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone analogue-induced gonadotropin withdrawal in the human. J Clin Endocrinol Metab 72:993-1000
30. Fraser HM, Groome NP, McNeilly AS 1999 Follicle-stimulating hormoneinhibin B interactions during the follicular phase of the primate menstrual cycle revealed by gonadotropin-releasing hormone analogue and antiestrogen treatment. J Clin Endocrinol Metab 84:1365-1369
31. Deghenghi R, Boutignon F, Wuthrich P, Lenaerts V 1993 Antarelix (EP 24332) a novel water soluble LHRH analogue. Biomed Pharmacother 47:107-110
32. Budwit-Novotny DA, McCarty KS, Cox EB, Soper JT, Mutch DG, Creasman WT, Flowers JL, McCarty Jr KS 1986 Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res 46:5419-5425
33. Lessey BA, Castelbaum AJ, Wolf L, Greene W, Paulson M, Meyer WR, Fritz MA 2000 Use of integrins to date the endometrium. Fertil Steril 73:779-787
34. Byskov AG 1974 Cell kinetic studies of follicular atresia in the mouse ovary. J Reprod Fertil 37:277-285
35. Lawler J, Hynes RO 1986 The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J Cell Biol 103:1635-1648
36. Wulff C, Wilson H, Largue P, Duncan WC, Armstrong DG, Fraser HM 2000 Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, tie-2, and vascular endothelial growth factor messenger ribonucleic acid. J Clin Endocrinol Metab 85:4302-4309
37. Greenaway J, Connor K, Pedersen HG, Coomber BL, LaMarre J, Petrik J 2004 Vascular endothelial growth factor and its receptor, Flk-1/KDR, are cytoprotective in the extravascular compartment of the ovarian follicle. Endocrinology 145:2896-2905
38. Agrawal R, Jacobs H, Payne N, Conway G 2002 Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil Steril 78:1164-1169
39. Franks S, Mason H, Willis D 2000 Follicular dynamics in the polycystic ovary syndrome. Mol Cell Endocrinol 163:49-52
40. Qian X, Wang TN, Rothman VL, Nicosia RF, Tuszynski GP 1997 Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells. Exp Cell Res 235:403-412
41. Lee KS, Min KH, Kim SR, Park SJ, Park HS, Jin GY, Lee YC 2006 Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma. Am J Respir Crit Care Med 174:161-170
42. Primo L, Ferrandi C, Roca C, Marchio S, di Blasio L, Alessio M, Bussolino F 2005 Identification of CD36 molecular features required for its in vitro angiostatic activity. FASEB J 19:1713-1715
43. Garvin S, Nilsson UW, Huss FR, Kratz G, Dabrosin C 2006 Estradiol increases VEGF in human breast studied by whole-tissue culture. Cell Tissue Res 325:245-251
44. Sengupta K, Banerjee S, Saxena NK, Banerjee SK 2004 Thombospondin-1 disrupts estrogen-induced endothelial cell proliferation and migration and its expression is suppressed by estradiol. Mol Cancer Res 2:150-158